Medicine and Dentistry
Prostate Cancer
100%
Positron Emission Tomography-Computed Tomography
40%
Fluorine-18
23%
Lymph Node
19%
Prospective Study
16%
Biological Marker
16%
Randomized Controlled Trial
16%
Bone Metastasis
13%
Quality of Life
13%
Lymph Node Metastasis
11%
Malignant Neoplasm
11%
Biopsy Technique
11%
Prostatectomy
8%
Bone Scintigraphy
8%
Magnetic Resonance Imaging
8%
Castration Resistant Prostate Cancer
8%
Pelvis
7%
Diseases
6%
Positron Emission Tomography
6%
Gleason Score
6%
Enzalutamide
6%
Abiraterone Acetate
6%
Systematic Review
6%
Prednisone
6%
Prostate Specific Antigen
6%
Choline
5%
Cancer Specific Survival
5%
Metastatic Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
78%
Biological Marker
18%
Castration Resistant Prostate Cancer
16%
Malignant Neoplasm
14%
Polyethylene Terephthalate
11%
Androgen
10%
Fluorine 18
10%
Prospective Study
10%
Enzalutamide
9%
Prednisone
9%
Prostate Specific Antigen
9%
Abiraterone Acetate
8%
Overall Survival
8%
Prevalence
7%
Placebo
7%
Bone Metastasis
6%
Observational Study
6%
Gleason Score
6%
Diseases
5%
Abiraterone
5%
Randomized Controlled Trial
5%